Ethics of Drug Studies in the Newborn

[1]  R. Kauffman,et al.  Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs, American Academy of Pediatrics. , 2018, Pediatrics.

[2]  J. Brady,et al.  The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. , 2014, The Journal of the American College of Dentists.

[3]  Steven Edward Kern,et al.  The pharmacokinetics of methadone and its metabolites in neonates, infants, and children , 2014, Paediatric anaesthesia.

[4]  M. Laughon,et al.  Drug labeling and exposure in neonates. , 2014, JAMA pediatrics.

[5]  D. Resnik.  What Are Reasonably Foreseeable Risks? , 2013, The American journal of bioethics : AJOB.

[6]  M. Roth-Cline,et al.  8. Ethical Considerations in Conducting Pediatric Research , 2013 .

[7]  M. Simar.  The Consent and Assent Process in Pediatric Clinical Trials , 2013 .

[8]  M. Walsh,et al.  Individual and Center-Level Factors Affecting Mortality Among Extremely Low Birth Weight Infants , 2013, Pediatrics.

[9]  E. Clayton,et al.  The OHRP and SUPPORT. , 2013, The New England journal of medicine.

[10]  F. Collins,et al.  In support of SUPPORT--a view from the NIH. , 2013, The New England journal of medicine.

[11]  J. Drazen,et al.  Informed consent and SUPPORT. , 2013, The New England journal of medicine.

[12]  Uses of drugs not described in the package insert (off-label uses). , 2013, Pediatrics.

[13]  C. Borradori-Tolsa,et al.  Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008 , 2012, BMC Pediatrics.

[14]  Nicolas Simon,et al.  Population Pharmacokinetic Analysis during the First 2 Years of Life , 2012, Clinical Pharmacokinetics.

[15]  B. Poindexter,et al.  Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Complicated Intra-abdominal Infections , 2011, The Pediatric infectious disease journal.

[16]  F. Rocchi,et al.  The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni. , 2011, Pharmacological research.

[17]  J. Millership.  Microassay of drugs and modern measurement techniques , 2011, Paediatric anaesthesia.

[18]  L. Doyle,et al.  Target ranges of oxygen saturation in extremely preterm infants. , 2010, The New England journal of medicine.

[19]  B. Poindexter,et al.  Target ranges of oxygen saturation in extremely preterm infants. , 2010, The New England journal of medicine.

[20]  R. Shaddy,et al.  Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations , 2010, Pediatrics.

[21]  A. Mulberg.  Pediatric Drug Development: Concepts and Applications , 2009 .

[22]  D. Kaufman,et al.  Population Pharmacokinetics of Fluconazole in Young Infants , 2008, Antimicrobial Agents and Chemotherapy.

[23]  Hui C. Kimko,et al.  Simulation for Designing Clinical Trials : A Pharmacokinetic-Pharmacodynamic Modeling Perspective , 2002 .

[24]  M. Allen,et al.  The Limit of Viability: Neonatal Outcome of Infants Born at 22 to 25 Weeksʼ Gestation , 1994 .

[25]  M. Allen,et al.  The Limit of Viability -- Neonatal Outcome of Infants Born at 22 to 25 Weeks' Gestation , 1993 .

[26]  William Ross,et al.  Categories of research , 1966 .

[27]  J. Hodgman,et al.  Fatal circulatory collapse in premature infants receiving chloramphenicol. , 1959, The New England journal of medicine.

[28]  D. Zatta.  Concepts and Application , 2016 .

[29]  Jason Gerson,et al.  Ethical considerations in conducting pediatric research. , 2011, Handbook of experimental pharmacology.

[30]  D. Notterman,et al.  Clinical Report—Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations , 2010 .

[31]  J. Somberg.  Pediatric drug development. , 2003, American journal of therapeutics.

[32]  B. Mirkin.  Clinical pharmacology and therapeutics--a pediatric perspective , 1978 .